| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 397.31 KB | Adobe PDF |
Advisor(s)
Abstract(s)
The phenomenon of aging is nowadays society as acquired the status of a social problem, with growing attention and concern, leading to an increase number of studies dedicated to the elderly. The lack of domestic, familiar or social support often lead elderly to nursing homes. Institutionalization is in many cases the only opportunity to have access to health care and life quality. Aging is also associated with a higher prevalence of chronic diseases that require long term medication sometimes for life. Frequently the onset of multiple pathologies at the same time require different therapies and the phenomenon of polypharmacy (five ou more drugs daily) can occur. Even more, the slow down of physiological and cognitives mechanisms associated with these chronic diseases can interphere, in one hand, with the pharmacocinetic of many medications and, on the other hand, with the facility to accomplish the therapeutical regimen. All of these realities contribute to an increase of pharmacotherapeutical complexity, decreasing the adherence and effectiveness of treatment. The pharmacotherapeutical complexity of an individual is characterized by the conciliator element of different characteristics of their drug therapy, such as: the number of medications used; dosage forms; dosing frequency and additional indications. It can be measured by the Medication Regimen Complexity Index (MRCI), originally validated in English.
Description
Keywords
Pharmacology Elderly Polypharmacy Chronic disease Institutionalization
Citation
Advinha A, Faísca VM, Pajote S, Lopes M, Graça A. Determination of pharmocotherapeutical complexity in institutionalized elderly. In XXII Congreso de la Sociedad Espñola de Farmacología Clínica, Badajoz (España), Novembro de 2009. Poster.